NSAIDs cut risk of pancreatitis post-ERCP 18 Apr 2012 0 comments A one-off suppository dose of NSAIDs almost halves the risk of developing pancreatitis after endoscopic retrograde cholangiopancreatography, a randomised trial finds.
Hep C anti-virals not as effective as trials suggest in some patients 11 Apr 2012 0 comments Doctors cannot assume results from clinical trials are transferable to their clinical practice, conclude the authors of a study showing Hepatatis C treatments in some patients are less effective than…
Side-effect fears stall hep C drugs 28 Mar 2012 0 comments Unexpectedly severe side effects are hampering the roll-out of two highly promising drugs for hepatitis C, an expert says, amid ongoing setbacks in securing PBS listings.
Exercise lowers NAFLD risk 14 Mar 2012 0 comments Even small amounts of exercise well under recommended levels can lessen the risk of NAFLD, and the effect is independent of weight loss, an Australian meta-analysis has shown.
New study praises transient elastography 7 Mar 2012 0 comments Ultrasound-based transient elastography is a highly useful diagnostic tool for liver transplant recipients, a new meta-analysis has concluded.
H. pylori linked to type 2 diabetes 8 Feb 2012 0 comments Older people infected with Helicobacter pylori could be at increased risk of developing type 2 diabetes compared with those with no sign of the infection, according to new research.
Metformin may reduce pancreatic cancer risk in women only 1 Feb 2012 0 comments The diabetes drug Metformin, previously linked with reduced pancreatic cancer risk, has been found by a new large-scale study to only lower risk in women.
Liver fibrosis: non-invasive assessment on the rise 8 Dec 2010 0 comments Liver biopsy to assess liver fibrosis is likely to be supplanted by non-invasive biochemical and imaging tests in the next few years, a recent review has claimed.
HCV status should not preclude renal transplant 29 Sep 2010 0 comments Hepatitis C virus status is a factor in decisions about renal dialysis and transplantation, but liver disease is not a major cause of worse renal outcomes and should not preclude these patients from…
Australian assay determines hep C treatment response 1 Sep 2010 0 comments Australian doctors have developed a genetic test that determines which hepatitis C positive patients will respond well to treatment.
